Home » Topics » BioWorld Science

BioWorld Science
RSS

Tanabe to develop marimastat

Nov. 20, 1996

Johns Hopkins University reports antiproliferative vitamin D3 analogue

Nov. 20, 1996

400-C, new FPTase inhibitor reported by Schering-Plough

Nov. 20, 1996

FPTase inhibitior series reported by Schering-Plough

Nov. 20, 1996

Fujisawa describes new agents for thrombocytopenia

Nov. 20, 1996

New farnesyl protein transferase series synthesized at Merck & Co.

Nov. 20, 1996

SKB reports D3-selective antipsychotic agents

Nov. 20, 1996

Analgesic kappa-opioid agonists reported by Pfizer

Nov. 20, 1996

Company Profile: Progenitor, Inc.

Nov. 20, 1996

Warner-Lambert claims lipid-regulating agents for vascular disease, diabetes

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...